Related Experiment Video

Updated: May 28, 2026

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
12:52

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

Evolving evidence implicates cytomegalovirus as a promoter of malignant glioma pathogenesis

Charles S Cobbs1

  • 1California Pacific Medical Center Research Institute, 475 Brannan Street, San Francisco, CA, 94114, USA. charles.cobbs@gmail.com.

Herpesviridae
|October 28, 2011
PubMed

Insights

Human cytomegalovirus (HCMV) drives malignant glioma growth by expressing proteins that promote tumor progression. Targeting HCMV offers a promising new strategy for treating glioblastoma multiforme (GBM).

Area of Science:

  • Oncology
  • Virology
  • Neuroscience

Background:

  • Malignant gliomas, particularly glioblastoma multiforme (GBM), are aggressive brain tumors with poor prognoses.
  • Human cytomegalovirus (HCMV) infection is increasingly recognized as a significant factor in glioma development and progression.
  • HCMV is a herpesvirus known to cause congenital infections and disease in immunocompromised individuals.

Purpose of the Study:

  • To review the role of HCMV gene products in promoting glioma pathogenesis.
  • To discuss specific HCMV proteins expressed in GBM and their impact on critical signaling pathways.
  • To explore emerging anti-HCMV therapeutic strategies for GBM.

Main Methods:

  • Review of existing literature and research findings on HCMV and malignant gliomas.
  • Analysis of specific HCMV gene products (IE1, US28, gB, IL-10) found in GBM.
  • Discussion of HCMV's influence on key signaling pathways (PDGFR, AKT, STAT3) and immune cells.

Main Results:

  • HCMV is universally present in human malignant gliomas.
  • HCMV proteins contribute to tumor growth by influencing mitogenesis, mutagenesis, apoptosis, inflammation, angiogenesis, invasion, and immuno-evasion.
  • HCMV gene products dysregulate essential glioma pathways, including PDGFR, AKT, and STAT3 signaling, and affect monocyte/microglia function.

Conclusions:

  • HCMV plays a critical role in the pathogenesis of malignant gliomas.
  • Targeting HCMV offers a novel therapeutic avenue for GBM treatment.
  • Emerging clinical trials are investigating anti-HCMV strategies for GBM.

More Related Videos

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections05:45

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections

Published on: July 31, 2017

Related Concept Videos

Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...